We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.00 | -0.06% | 1,727.50 | 1,727.00 | 1,728.00 | 1,739.50 | 1,724.50 | 1,733.00 | 1,225,454 | 12:55:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.44 | 71.14B |
Date | Subject | Author | Discuss |
---|---|---|---|
28/6/2017 19:56 | What economics model? LOL. | alphorn | |
28/6/2017 19:41 | I think Carney (a Canadian) is not right for this country and its economics model. | tradermichael | |
28/6/2017 15:48 | Well the BOE is behind the curve, only because the Tories wanted no increases before the election, get in with a substantially better majority then light the fuse..well they are now between a rock and a hard place lol Still they are going to have to start raising rates, sooner the better, otherwise, they may need go raise rates higher & quicker than planned, which will send shock waves around a very toppy market. I will wait for 1652p or better. | ny boy | |
28/6/2017 14:53 | Carney's just opened his mouth again ;-) 'Pound spikes after Mark Carney says higher interest rates will be "necessary"' | philanderer | |
28/6/2017 09:40 | Worst case scenario 1590p support, may see a retrace to 1652p, not enough fuel to get through 1715p yet. Nice quarterly divi though. | ny boy | |
28/6/2017 09:17 | I sold at 1710 and I'm just glad not to have made an instant notional loss. | grahamite2 | |
28/6/2017 09:14 | I would like to suggest that a close below 1680 is bearish with an opportunity to short down to 1560. Having been short from 1718 I may be seeing what I want to see! | toffeeman | |
28/6/2017 09:10 | IN, 8579 shares @ 1676.98 ......;0) | tradermichael | |
27/6/2017 15:26 | On the R&D spend is he comparing the % as group turnover or as a % of the pharmaceutical business? The consumer side needs a lot less R&D and can sustain more debt | dr biotech | |
27/6/2017 14:47 | There may be a question of where the cash balances are sitting and how they get repatriated to the parent company. Often an issue with international groups. | alphorn | |
27/6/2017 14:44 | I don't necessarily disagree with the content, but on point 3, the CFO has been explicit about wanting to carry more debt because it's cost-effective financing. Personally, I think it's crazy to borrow money to pay dividends & invest when you already have a cash mountain, albeit one that's bleeding dividends, but what do I know? | zzaxx99 | |
25/6/2017 21:21 | GlaxoSmithKline: 3 Reasons You Should Be Concerned | philanderer | |
23/6/2017 08:03 | Getting nervous here ..... the GSK rise has happened too quickly, the DJ is at record highs, UK/EU politics is dragging the economy ..... I made 3 sales on the way here: 31 May: 9078 @ 1696.00 31 May: 5484 @ 1703.69 22 Jun: 7868 @ 1719.63 Kept the rest (12611). Will be back in on the next big drop ..... ;0) | tradermichael | |
22/6/2017 22:32 | New GSK chief kicks off shake-up with Maximuscle sale The drugs giant's new boss is pushing the button on a sale of its MaxiNutrition range of sports supplements, Sky News learns. | philanderer | |
22/6/2017 17:49 | Looking good , strong day :-) | philanderer | |
22/6/2017 08:59 | LONDON-- GlaxoSmithKline PLC (GSK.LN) Wednesday said a Phase III study of its shingles vaccine Shingrix showed a strong immune response in older adults, meeting its primary objective | tradermichael | |
22/6/2017 08:02 | GSK: A U.S. jury has ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg, court documents showed. | fangorn2 | |
20/6/2017 20:54 | Drug price scandals hit global pharma growth forecasts | philanderer | |
20/6/2017 20:26 | Just about held it today , it`s a start ;-) | philanderer | |
20/6/2017 14:20 | I say no - but I would, wouldn't cos I am short from just above. | toffeeman | |
20/6/2017 14:19 | Would you guys say that its likely to hold 1700p this time? ....... ;o) | tradermichael | |
19/6/2017 12:52 | Added to long position this morning. | alphorn | |
19/6/2017 09:38 | I`ve had a small top up this morning. I like the look of the chart. Morning everyone. | philanderer | |
16/6/2017 09:57 | Thanks M_K_Hubbert - a good overview there. And thanks to others, too. | tradermichael | |
16/6/2017 09:52 | 16th june Jefferies buy tp 1900p up from 1800p | philanderer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions